𝔖 Bobbio Scriptorium

✦ LIBER ✦

ChemInform Abstract: Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) for the Treatment of Human Immunodeficiency Virus Type 1 (HIV-1) Infections: Strategies to Overcome Drug Resistance Development

✍ Scribed by E. DE CLERCQ

Book ID: 112034527
Publisher: John Wiley and Sons
Year: 2010
Weight: 25 KB
Volume: 27
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.199628326

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sensitivity/Resistance Profile of a Simi

Sensitivity/Resistance Profile of a Simian Immunodeficiency Virus Containing the Reverse Transcriptase Gene of Human Immunodeficiency Virus Type 1 (HIV-1) Toward the HIV-1-Specific Non-nucleoside Reverse Transcriptase Inhibitors

✍ J. Balzarini; M. Weeger; M.J. Camarasa; E. Declercq; K. Uberla 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 388 KB

ChemInform Abstract: Novel Non-Nucleosid

ChemInform Abstract: Novel Non-Nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase. Part 4. 2-Substituted Dipyridodiazepinones as Potent Inhibitors of Both Wild-Type and Cysteine-181 HIV-1 Reverse Transcriptase Enzymes.

✍ J. R. PROUDFOOT; K. D. HARGRAVE; S. R. KAPADIA; U. R. PATEL; K. G. GROZINGER; D. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 34 KB

55 Selection of human immunodeficiency v

55 Selection of human immunodeficiency virus type 1 (Hiv-1) resistant to the nucleoside inhibitor 2′,3′-dideoxy-5-fluoro-3′-thiacytidine (Ftc) in cell culture due to a single mutation in the reverse transcriptase: M. Tisdale, N. R. Parry, S. D. Kemp and B. A. Larder, Department of Molecular Sciences, The Wellcome Research Laboratories, Beckenham, Kent BR3 3BS, U.K.

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 65 KB